SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AGHAZADEH TABRIZI, Mojgan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.963
EU - Europa 4.008
AS - Asia 1.629
SA - Sud America 18
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
Totale 14.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.937
DE - Germania 1.778
CN - Cina 910
UA - Ucraina 622
TR - Turchia 466
RU - Federazione Russa 404
IT - Italia 355
GB - Regno Unito 306
SE - Svezia 230
SG - Singapore 169
FI - Finlandia 134
PL - Polonia 60
FR - Francia 31
VN - Vietnam 30
BE - Belgio 29
CA - Canada 23
CZ - Repubblica Ceca 17
HK - Hong Kong 13
NL - Olanda 10
IN - India 9
AU - Australia 8
BR - Brasile 8
EU - Europa 7
IL - Israele 6
LT - Lituania 6
AR - Argentina 5
CL - Cile 4
ID - Indonesia 4
IR - Iran 4
KR - Corea 4
AT - Austria 3
GR - Grecia 3
IE - Irlanda 3
MA - Marocco 3
PK - Pakistan 3
BG - Bulgaria 2
CH - Svizzera 2
JP - Giappone 2
MX - Messico 2
RO - Romania 2
TW - Taiwan 2
BD - Bangladesh 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
MC - Monaco 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 14.638
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.266
Fairfield 1.203
Houston 728
Jacksonville 696
Ann Arbor 684
Ashburn 603
Chandler 574
Wilmington 496
Seattle 495
Cambridge 393
Izmir 220
Beijing 197
Nanjing 184
Ferrara 152
Princeton 145
Boardman 142
San Diego 110
Singapore 106
Shanghai 89
Milan 76
Bremen 74
Shenyang 61
Nanchang 59
Warsaw 59
New York 48
Changsha 46
Hebei 44
San Mateo 43
Jiaxing 38
Tianjin 36
Dong Ket 29
Falls Church 29
Dearborn 28
Jinan 27
London 27
Brussels 25
Philadelphia 25
Redwood City 25
Mountain View 22
Addison 21
Zhengzhou 21
Kunming 20
Brno 15
Los Angeles 15
Orange 15
Auburn Hills 14
Indiana 14
Guangzhou 13
Washington 13
Ningbo 12
Norwalk 12
Des Moines 11
Hangzhou 11
Munich 11
Tappahannock 11
Bari 10
Hong Kong 10
Helsinki 8
Taizhou 8
Mcallen 7
Montréal 7
Chicago 6
Kilburn 6
Redmond 6
Amsterdam 5
Düsseldorf 5
Haikou 5
Lanzhou 5
Acton 4
Chiswick 4
Hefei 4
San Francisco 4
Toronto 4
Verona 4
Vilnius 4
Yellow Springs 4
Florence 3
Guelph 3
Hounslow 3
Jakarta 3
Mysore 3
Padova 3
Prescot 3
Tel Aviv 3
Vilvoorde 3
Xian 3
Albany 2
Buenos Aires 2
Calvizzano 2
Chongqing 2
Dublin 2
Federal 2
Fuzhou 2
Kitzbuhel 2
New Delhi 2
Olomouc 2
Piscataway 2
Rio de Janeiro 2
Rome 2
Salice Salentino 2
Totale 9.711
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 314
Handbook of Cannabis and Related Pathologies 250
A glance at adenosine receptors: Novel target for antitumor therapy 193
The A3 adenosine receptor: history and perspectives 160
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 152
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 151
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 149
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 147
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 146
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 145
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 143
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 140
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 140
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 139
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 138
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 138
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 137
Adenosine receptors and human melanoma 137
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 136
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 133
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 133
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 133
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 132
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 132
DNA minor groove binders as potential antitumor and antimicrobial agents 131
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 131
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 131
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 130
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 130
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 129
Hybrid molecules based on distamycin A as potential antitumor agents 128
Allosteric modulators for the A1-adenosine receptor 127
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 127
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 126
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 125
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 124
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 124
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 123
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 122
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 122
null 121
Recent improvements in the development of A2B adenosine receptor agonists. 121
null 121
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 120
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 120
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 120
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 120
A3 adenosine receptor antagonists: History and future perspectives 120
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 120
null 120
null 118
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists. 116
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 115
null 113
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 113
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 113
Allosteric enhancers for A(1) adenosine receptor 112
null 112
null 112
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 112
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 112
Hybrid molecules between distamycin A and active moieties of antitumor agents 112
Recent improvements in the development of A2B adenosine receptor agonists 111
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents 111
null 110
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 110
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 110
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 109
null 109
Recent developments in A2B adenosine receptor ligands 108
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease. 108
null 107
null 104
New synthesis of diazepino[3,2,1-ij]quinoline and pyrido[1,2,3-de] quinoxalines via addition-elimination followed by cycloacylation 104
null 103
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 102
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 100
Recent developments in the field of adenosine receptor ligands. 100
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 99
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 99
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked heterocycles as template for the adenosine receptor antagonism: medicinal chemistry approach and SAR considerations. 97
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 97
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 97
null 96
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 95
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 95
Synthesis and biological evaluation of 2-substituted-4-(3 ',4 ',5 '-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents 95
Preparation of substituted purinylpyrazolylacetamides as adenosine A2B receptor antagonists. 94
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 92
null 92
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 92
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 91
New strategies for the synthesis of A(3) adenosine receptor antagonists 89
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 88
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 88
A structural study of new potent and selective antagonists to the A(2B) adenosine receptor 88
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 87
null 87
null 87
Totale 12.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.302
Totale 51.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.879 464 103 103 429 190 329 239 282 228 286 173 53
2020/20212.081 267 203 85 229 141 221 55 228 43 267 210 132
2021/20221.546 58 144 147 53 98 78 79 53 57 118 150 511
2022/20231.389 142 82 26 183 291 209 58 109 171 10 67 41
2023/2024752 67 94 43 28 56 111 38 74 13 10 11 207
2024/202556 56 0 0 0 0 0 0 0 0 0 0 0
Totale 14.813